Novel science thrives on collaboration. Our innovative DEL-AI platform and our leadership in the protein degradation field have attracted partnerships with industry-leading pharmaceutical companies. These strategic alliances validate our cutting-edge approach while significantly expanding our reach and impact. Together, we’re accelerating the development of novel therapies across a diverse range of disease areas.